David B Jones

Array ( [id] => 6886561 [patent_doc_number] => 20010019830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'Method of screening for pharmaceuticals by detecting cross talk between intracellular signals and intranuclear receptors' [patent_app_type] => new [patent_app_number] => 09/848588 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5403 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20010019830.pdf [firstpage_image] =>[orig_patent_app_number] => 09848588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815409 [patent_doc_number] => 20020040132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Methods' [patent_app_type] => new [patent_app_number] => 09/845771 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5140 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040132.pdf [firstpage_image] =>[orig_patent_app_number] => 09845771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083058 [patent_doc_number] => 20020082412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Methods' [patent_app_type] => new [patent_app_number] => 09/845720 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5122 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082412.pdf [firstpage_image] =>[orig_patent_app_number] => 09845720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6224489 [patent_doc_number] => 20020004226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Soluble LDL receptor, its production and use' [patent_app_type] => new [patent_app_number] => 09/824637 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12717 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004226.pdf [firstpage_image] =>[orig_patent_app_number] => 09824637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231942 [patent_doc_number] => 06693170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'ARIP4 gene and protein' [patent_app_type] => B2 [patent_app_number] => 09/824574 [patent_app_country] => US [patent_app_date] => 2001-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13475 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693170.pdf [firstpage_image] =>[orig_patent_app_number] => 09824574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432890 [patent_doc_number] => 20020127638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Human metabotropic glutamate receptor 7 subtypes' [patent_app_type] => new [patent_app_number] => 09/817464 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14126 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127638.pdf [firstpage_image] =>[orig_patent_app_number] => 09817464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613541 [patent_doc_number] => 20020015966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Effector-specific protein assembly and uses thereof' [patent_app_type] => new [patent_app_number] => 09/815416 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8750 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015966.pdf [firstpage_image] =>[orig_patent_app_number] => 09815416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6404941 [patent_doc_number] => 20020037514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Identification of nuclear receptor-dependent coregulator recruitment' [patent_app_type] => new [patent_app_number] => 09/815156 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16309 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037514.pdf [firstpage_image] =>[orig_patent_app_number] => 09815156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6208979 [patent_doc_number] => 20020072076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Method for testing a substance interacting with a hormone receptor' [patent_app_type] => new [patent_app_number] => 09/815068 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13871 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072076.pdf [firstpage_image] =>[orig_patent_app_number] => 09815068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755740 [patent_doc_number] => 20030003517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Methods of detecting dissociated nuclear hormone receptor ligands' [patent_app_type] => new [patent_app_number] => 09/814604 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16298 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003517.pdf [firstpage_image] =>[orig_patent_app_number] => 09814604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1346196 [patent_doc_number] => 06579686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-17 [patent_title] => 'Constitutive androstane receptor' [patent_app_type] => B2 [patent_app_number] => 09/814569 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5382 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579686.pdf [firstpage_image] =>[orig_patent_app_number] => 09814569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985878 [patent_doc_number] => 20020098539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Histamine receptor' [patent_app_type] => new [patent_app_number] => 09/812216 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14780 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098539.pdf [firstpage_image] =>[orig_patent_app_number] => 09812216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860990 [patent_doc_number] => 20030091998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Association of beta2-adrenergic receptor haplotypes with drug response' [patent_app_type] => new [patent_app_number] => 09/811285 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19454 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091998.pdf [firstpage_image] =>[orig_patent_app_number] => 09811285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015342 [patent_doc_number] => 20010051712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Association of beta2-adrenergic receptor haplotypes with drug response' [patent_app_type] => new [patent_app_number] => 09/811286 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19879 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051712.pdf [firstpage_image] =>[orig_patent_app_number] => 09811286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175696 [patent_doc_number] => 20020155446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Very low density lipoprotein receptor polymorphisms and uses therefor' [patent_app_type] => new [patent_app_number] => 09/802320 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11536 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155446.pdf [firstpage_image] =>[orig_patent_app_number] => 09802320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869845 [patent_doc_number] => 20030082534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Novel G protein-coupled receptors' [patent_app_type] => new [patent_app_number] => 09/782974 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56447 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082534.pdf [firstpage_image] =>[orig_patent_app_number] => 09782974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462411 [patent_doc_number] => 20020150582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Method of treating or inhibiting cellular injury or cell death' [patent_app_type] => new [patent_app_number] => 09/779039 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5263 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150582.pdf [firstpage_image] =>[orig_patent_app_number] => 09779039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629598 [patent_doc_number] => 06818758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Estrogen receptor beta variants and methods of detection thereof' [patent_app_type] => B2 [patent_app_number] => 09/768185 [patent_app_country] => US [patent_app_date] => 2001-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 15 [patent_no_of_words] => 63819 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818758.pdf [firstpage_image] =>[orig_patent_app_number] => 09768185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 737878 [patent_doc_number] => 07034105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy' [patent_app_type] => utility [patent_app_number] => 09/765534 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 37975 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034105.pdf [firstpage_image] =>[orig_patent_app_number] => 09765534 [rel_patent_id] =>[rel_patent_doc_number] =>)